SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Osisko Development Corp. changed its corporate name to Osisko Gold Group Inc. and relocated its registered office from Québec to Ontario, effective July 14, 2026, following shareholder approval on June 23, 2026. The name change triggered corresponding ticker symbol changes across TSXV, NYSE, and Nasdaq (ODV to OGG, ODVWZ to OGGWZ), along with new CUSIP and ISIN numbers.
View raw filing on EDGAR →Oncolytics announced that the FDA granted Fast Track Designation for pelareorep in combination with a checkpoint inhibitor for treating advanced squamous cell carcinoma of the anal canal. This is a significant regulatory milestone that accelerates development and review timelines, represents the third Fast Track designation in gastrointestinal cancers, and addresses an estimated $1 billion market with no approved therapies for second-line patients. While this is a positive regulatory development rather than a traditional operational event, it is a material strategic and regulatory milestone that would affect investor assessment of the company's development trajectory and de-risking of its pipeline.
View raw filing on EDGAR →This is a clear earnings release disclosing quarterly and six-month financial results for Farmers & Merchants Bancorp. The press release reports record second quarter net income of $24.7 million, diluted EPS of $36.39 (up 10.47% YoY), and detailed financial metrics including net interest income, balance sheet growth, and capital ratios. The filing explicitly states "On July 20, 2026, Farmers & Merchants Bancorp issued a press release concerning financial results for the three-months and six-months ended June 30, 2026" and includes comprehensive financial highlights and management commentary typical of an earnings announcement.
View raw filing on EDGAR →This press release announces clinical progress in a Phase 2 trial of MP0317 for cholangiocarcinoma, including dosing of first patients, nine activated trial sites, and expected data in 2027. While this is a material operational milestone for a clinical-stage biotech company, it does not fit the specific `earnings_release` category (no financial results disclosed) nor any other named event type. The disclosure is clearly operational—a significant clinical development milestone—making `operational_other` the appropriate classification.
View raw filing on EDGAR →ServisFirst Bancshares issued a press release on July 20, 2026 announcing second quarter 2026 operating results, disclosing net income of $85.8 million (up 39.7% year-over-year), diluted EPS of $1.57 (up 40% year-over-year), and key metrics including loan growth, deposit growth, and net interest margin expansion.
View raw filing on EDGAR →Enzo Villani, who was Executive Chairman and Chief Investment Officer, has been appointed to serve as President of Alpha Compute Corp, effective July 16, 2026. This is a material executive appointment expanding his role to include "broader responsibility for corporate strategy, capital allocation, and operational execution." The appointment of a senior executive to a new C-suite position is material to investors assessing company leadership and governance.
View raw filing on EDGAR →ServisFirst's Board declared a two-for-one stock split effected as a 100% stock dividend, with stockholders of record on August 5, 2026 receiving one additional share for each share held on the distribution date of August 20, 2026. This is a return of capital to shareholders in the form of a stock dividend, which falls squarely within the dividend_distribution category. While material to shareholders, the event is a routine capital structure action rather than an earnings release or other operational event.
View raw filing on EDGAR →Monarch Casino & Resort disclosed second quarter 2026 financial results via press release, reporting net revenue of $142.6 million (up 4.2% YoY), net income of $32.5 million (up 20.4% YoY), and diluted EPS of $1.78 (up 23.6% YoY), along with detailed operating metrics.
View raw filing on EDGAR →The company declared a quarterly cash dividend of $0.30 per share payable on September 15, 2026, to stockholders of record on September 1, 2026, as part of its $1.20 annual dividend program.
View raw filing on EDGAR →This is a straightforward quarterly earnings release for Q2 2026. The filing discloses consolidated financial results including net income of $7,155,000 ($0.67 per share), net interest income, provision for credit losses, and comprehensive balance sheet and income statement data. The press release titled "Muncy Columbia Financial Corporation Announces Second Quarter 2026 Earnings" is attached as Exhibit 99.1 and incorporated by reference, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →The exhibit discloses that a Special Committee of the Board is actively evaluating two acquisition proposals: one from a group including Meir Shamir and the CEO, and another from Steel Partners Holdings L.P. to acquire 100% of the Company. This constitutes material M&A activity under Item 1.01 / 2.01 equivalent, as the Committee is formally engaged in reviewing and will make recommendations on potential change-of-control transactions that would materially affect the registrant's structure and shareholder interests.
View raw filing on EDGAR →The filing discloses the appointment of Liisa Bayko as Chief Financial Officer and Treasurer effective July 20, 2026, along with detailed employment terms including $475,000 base salary, up to 40% annual bonus, and a 220,000-share stock option grant. While the section also mentions Brett Hagen's resignation as Chief Accounting Officer and Amy Vandekop's interim appointment, the primary and most substantive disclosure centers on Bayko's appointment as CFO with comprehensive compensation arrangements. This is a material executive appointment affecting the company's financial leadership.
View raw filing on EDGAR →Goldman Sachs announced the launch of a proposed public offering of depositary shares representing interests in a new series of Fixed-Rate Reset Non-Cumulative Preferred Stock, Series AA. While technically equity (preferred stock), this instrument creates a direct financial obligation with fixed-rate terms and is economically similar to debt. The company intends to use proceeds to redeem existing Series U Preferred Stock, indicating a refinancing of capital structure. This is material to investors as it affects the company's capital composition and financial obligations.
View raw filing on EDGAR →Galaxy Gaming disclosed that a previously announced merger agreement with Evolution Malta Holding Limited has not closed by the July 17, 2026 outside date due to unsatisfied regulatory conditions, and the company is now evaluating options including seeking an extension or terminating the agreement. This is a material update on the status of a merger transaction that has been pending for two years, directly affecting the registrant's strategic direction and shareholder value.
View raw filing on EDGAR →The disclosure reports positive 2-year efficacy and safety data from the PRISM Phase 2b clinical trial of 4D-150 for wet AMD, including consistent BCVA maintenance, CST control, and significant treatment burden reduction (78–87% fewer injections). This represents a material clinical milestone for a biopharmaceutical company advancing toward Phase 3 trials, affecting investor assessment of the therapeutic candidate's viability and commercial potential. While not a specific named event type, this is clearly an operational/clinical development milestone that would influence a reasonable investor's view of the company's pipeline progress.
View raw filing on EDGAR →Tempus AI announced entry into a definitive Agreement and Plan of Merger to acquire Personalis, Inc. for $16.25 per share ($1.5 billion enterprise value). The disclosure describes a two-step merger structure with Tempus subsidiaries, subject to shareholder approval and regulatory clearances, with expected closing in late 2026 or early 2027. This is a material acquisition that would substantially affect the registrant's business, assets, and capital structure.
View raw filing on EDGAR →This exhibit discloses Wipro's audited standalone and consolidated financial results for the quarter ended June 30, 2026, approved by the Board on July 16, 2026. The filing includes complete quarterly income statements, profit/loss figures, EPS data, and auditor's reports with unmodified opinions. This is a discrete earnings announcement, not a periodic report filing itself, and would materially affect investor assessment of the company's quarterly performance.
View raw filing on EDGAR →The filing discloses that Hancock Whitney Corporation has received regulatory approval from the Federal Reserve, FDIC, and Mississippi Department of Banking to complete its previously announced acquisition of OFB Bancshares (parent of One Florida Bank), and that OFB Bancshares shareholders have approved the merger agreement. The acquisition is expected to close on or about August 1, 2026. This is a material acquisition event at an advanced stage (regulatory and shareholder approvals obtained, pending only customary closing conditions).
View raw filing on EDGAR →Personalis entered into a definitive Agreement and Plan of Merger with Tempus AI, Inc., whereby Tempus will acquire all outstanding Personalis shares at $16.25 per share, representing a total enterprise value of $1.5 billion, with closing expected in late 2026 or early 2027, subject to shareholder approval and regulatory clearances.
View raw filing on EDGAR →The Company amended its fee letter with Citibank to increase the Facility Amount from $500 million to $750 million, materially expanding its borrowing capacity and direct financial obligations under the credit facility.
View raw filing on EDGAR →Damora Therapeutics completed a redomestication from Delaware to the Cayman Islands, effective July 16, 2026, following stockholder approval at a Special Meeting on February 9, 2026. The redomestication involved automatic conversion of all share classes, issuance of a new CUSIP, and amendments to the company's articles of association and bylaws, materially modifying shareholder rights and the company's legal jurisdiction and governance framework.
View raw filing on EDGAR →The filing discloses an unsolicited acquisition proposal from the company's Chair and CEO, Omid Farokhzad, to acquire all outstanding shares at $2.45 per share plus contingent value rights. Although the Special Committee unanimously rejected the proposal, the receipt and rejection of a material acquisition proposal from a controlling shareholder is a significant M&A-related event that would materially affect a reasonable investor's assessment of the company's prospects and control dynamics.
View raw filing on EDGAR →Nir Naor was appointed as Executive Vice President and Chief Financial Officer effective July 23, 2026, with a compensation package including $480,000 base salary and a 500,000 RSU inducement grant. The appointment reflects the company's focus on strengthening financial oversight with an executive bringing 20+ years of finance and life sciences experience.
View raw filing on EDGAR →Public Storage completed the issuance of $400 million 4.700% Senior Notes due 2032 and $500 million 5.150% Senior Notes due 2036, totaling $900 million in new direct financial obligations pursuant to supplemental indentures dated July 20, 2026.
View raw filing on EDGAR →LM Funding America, Inc. changed its corporate name to PowerCompute, Inc. and its ticker symbol from LMFA to PWCM, effective July 22, 2026, with conforming amendments to bylaws. While the company emphasized a strategic business transformation toward high-performance computing and AI infrastructure, the 8-K disclosure itself is a governance/administrative matter affecting corporate identity and trading symbol.
View raw filing on EDGAR →Wabash National completed a private offering of $150 million in aggregate principal amount of 4.00% Convertible Senior Notes due 2032 (including the $20 million overallotment exercised by initial purchasers). The convertible notes are unsecured senior obligations with conversion features allowing holders to convert into up to 11,867,085 shares of common stock at an initial conversion rate of 79.1139 shares per $1,000 principal amount. Net proceeds of approximately $122 million (or $141 million with full option exercise) are intended for general corporate purposes including repayment of existing credit agreement amounts.
View raw filing on EDGAR →The filing discloses a declaration of a return of capital distribution of $0.62 per share (7.5% of NAV) to shareholders, representing a material capital return. This is a classic dividend_distribution event—a declared distribution to shareholders. The materiality is evident from the substantial magnitude ($3.54 per share returned over four months, representing 43% of December 31, 2025 NAV) and the company's strategic commitment to return 50% or more of NAV by year-end 2026.
View raw filing on EDGAR →T Series BDC LLC amended and restated its credit facility with Barclays Bank PLC, increasing the facility amount from $600 million to $800 million, representing a material $200 million increase in available borrowing capacity and direct financial obligations.
View raw filing on EDGAR →Sangamo Therapeutics filed a voluntary petition for Chapter 11 bankruptcy relief on June 23, 2026 (Case No. 26-10989) in the U.S. Bankruptcy Court for the District of Delaware. The company is operating as a debtor-in-possession and has obtained court approval for bidding procedures to sell substantially all assets.
View raw filing on EDGAR →The Nasdaq Hearings Panel issued a final delisting determination denying Sangamo's request to continue listing on The Nasdaq Capital Market due to failure to meet the minimum bid price requirement. The company's stock has been suspended from Nasdaq and is now trading on the OTCID Basic Market, with Nasdaq expected to file a Form 25 to delist and deregister the common stock.
View raw filing on EDGAR →Tempus AI entered into an Agreement and Plan of Merger with Personalis, Inc. on July 20, 2026, whereby Tempus will acquire Personalis through a two-step merger structure. The filing discloses detailed merger consideration (stock and cash), closing conditions, representations and warranties, and interim operating covenants—all hallmarks of a material acquisition. This is a classic Item 1.01 disclosure of entry into a material definitive agreement for M&A activity.
View raw filing on EDGAR →MasTec disclosed the drawdown of $700 million under a new senior unsecured delayed draw term loan agreement and $600 million under an amended credit facility on July 20, 2026, creating direct financial obligations totaling $1.3 billion. The filing explicitly states these borrowings were used to finance the cash consideration for the Superior Group acquisition and related fees and expenses, representing material debt issuance activity under Item 2.03.
View raw filing on EDGAR →Personalis entered into an Agreement and Plan of Merger with Tempus AI, Inc. on July 20, 2026, whereby Personalis will merge with Tempus subsidiaries and become a wholly-owned subsidiary of Tempus. The disclosure details the merger consideration (stock and cash), treatment of equity awards, closing conditions, and representations/warranties—all hallmarks of a material acquisition/change of control transaction under Item 1.01.
View raw filing on EDGAR →The exhibit discloses the exercise of 1,015,511 warrants by Kreos Capital VII Aggregator SCSp, resulting in the issuance of 577,237 new shares through a net exercise mechanism. This represents a dilutive equity issuance tied to a financing arrangement (warrant agreement dated December 23, 2025). The registration of these shares with the Finnish Trade Register increases the total share count from approximately 262.5 million to 263,039,597 shares, materially affecting shareholder ownership percentages and voting power.
View raw filing on EDGAR →Research Alliance Corp IV consummated its initial public offering on July 14, 2026, raising $75 million in gross proceeds from the sale of 7.5 million Class A ordinary shares at $10.00 per share, plus a concurrent private placement of 275,000 shares for $2.75 million. While technically an IPO rather than a traditional M&A transaction, this represents a material capital-raising event that establishes the company as a blank-check SPAC formed to effect a future business combination. The disclosure emphasizes the company's purpose to effect a merger, share exchange, or similar business combination, and the trust account structure is central to the SPAC framework. This is material to investors as it fundamentally establishes the company's capital structure and acquisition vehicle status.
View raw filing on EDGAR →The disclosure explicitly reports the dismissal of PricewaterhouseCoopers LLP as the independent registered public accounting firm on July 14, 2026, and the simultaneous appointment of BDO USA, P.C. as the new auditor. This is a classic auditor change event under Item 4.01. The filing confirms no disagreements, reportable events, or adverse audit opinions, indicating a routine transition rather than a crisis-driven change. Auditor changes are material to investors as they affect financial statement reliability and oversight.
View raw filing on EDGAR →Energy Transfer LP completed a public offering of $1.75 billion in aggregate principal amount of junior subordinated notes (Series 2026A and Series 2026B Notes due 2057) under supplemental indentures dated July 20, 2026.
View raw filing on EDGAR →The filing discloses a shareholder letter outlining SmartStop's strategic framework called "The Deca Initiative," a long-term plan to grow the company to $10 billion in total capitalization. The letter details operational and strategic initiatives including disciplined capital allocation, clustering and margin expansion, AI integration, and third-party management scaling. While this is a material strategic disclosure that would affect investor assessment of the company's direction and growth prospects, it does not fit neatly into specific event categories (not M&A, not a specific operational milestone, not a material contract). This is best classified as an operational strategic disclosure that does not fit a named category.
View raw filing on EDGAR →Cemex disclosed receipt of a Statement of Objections from the European Commission regarding antitrust investigations initiated in 2023 concerning the company's admixtures activity in France and Germany. While the company states it cannot yet assess the likely outcome or material adverse impact, the initiation of formal EC enforcement proceedings (evidenced by the SO) is a material regulatory event that would affect a reasonable investor's assessment of legal and financial risk. This is a legal/regulatory matter that does not fit the specific `material_litigation` category (which typically covers lawsuits and settlements) but clearly qualifies as a material legal event.
View raw filing on EDGAR →Vulcan Infrastructure & Power Inc. completed a $39.4 million PIPE transaction consisting of $29.4 million in Class A common stock issued at $1.71 per share to institutional and insider investors (Machine Investment Group, Atlas Holdings, Conversant Capital), plus a $10 million convertible note and warrants. The company will use proceeds to redeem approximately $33 million of outstanding senior notes due October 2026.
View raw filing on EDGAR →The company issued $10 million principal amount of 10% secured convertible notes to Machine Investment Group, convertible into Class A common stock at $2.13 per share with a three-year warrant, creating a new direct financial obligation on the balance sheet.
View raw filing on EDGAR →Stockholders approved by written consent on July 19, 2026, the issuance of PIPE shares, convertible notes, warrants, and sponsor incentive shares under Nasdaq Rule 5635(b), and the adoption of a new equity plan under Nasdaq Rule 5635(c).
View raw filing on EDGAR →The filing discloses a proposed acquisition of Element Solutions Inc. by Solstice Advanced Materials Inc., announced via an investor update presentation on July 20, 2026. The 8-K Item 7.01 explicitly states "Solstice Advanced Materials Inc., a Delaware corporation ("Solstice") issued an investor update presentation regarding the proposed acquisition of Element Solutions Inc." This is a material acquisition activity that would substantially affect a reasonable investor's assessment of the registrant, involving synergies, combined EBITDA projections, and significant shareholder voting requirements.
View raw filing on EDGAR →The filing discloses that Tenon Medical regained compliance with Nasdaq's Stockholders' Equity Rule (minimum $2.5 million) following a $4.2 million public offering on July 1, 2026. However, the company explicitly warns that "if the Company fails to evidence compliance upon filing its Quarterly Report on Form 10-Q for the period ending September 30, 2026, the Company may be subject to delisting." This is a material delisting risk disclosure under Item 8.01, as the company faces potential delisting if it cannot maintain the minimum equity threshold in its next quarterly report.
View raw filing on EDGAR →Aptorum Group Limited completed its merger with DiamiR Biosciences Corp. on July 20, 2026, with the combined entity domesticated to Delaware and renamed Niki BioSolutions, Inc., trading under ticker 'NIKI'. The transaction involved the issuance of shares to both Aptorum and DiamiR shareholders, constituting a material change of control and business combination.
View raw filing on EDGAR →The exhibit discloses a proposed at-the-market (ATM) offering program of up to $200 million in American Depositary Shares (ADSs) representing ordinary shares, filed with the SEC on Form F-3. This is an unregistered equity issuance that will dilute existing shareholders. The announcement explicitly states the Company expects the underlying ordinary shares to represent up to 20% of total issued shares, and the offering is subject to Hong Kong listing rule waivers. This is a material capital-raising event that would affect investor assessment of ownership dilution and the Company's financing strategy.
View raw filing on EDGAR →The 6-K discloses termination of an at-the-market (ATM) offering agreement with AC Sunshine Securities LLC, under which the Company had sold 3,487,171 ordinary shares (approximately 96% of the $200 million authorized offering) as of July 11, 2026. While the termination itself is the headline event, the substance is the dilutive equity issuance that occurred under the ATM program. This represents a material capital-raising activity that would affect a reasonable investor's assessment of share dilution and the Company's financing strategy.
View raw filing on EDGAR →Big Digital Energy completed the acquisition of a 50-acre industrial site in Hood County, Texas through a 50/50 joint venture with 10NetZero for approximately $10 million in cash on July 14-15, 2026. The company acquired a 50% membership interest in the joint venture, securing a power-ready development asset with 17 MW operational power expandable to 111 MW grid capacity and up to 300 MW total buildout potential, representing a strategic asset central to the company's AI infrastructure platform strategy.
View raw filing on EDGAR →This press release announces a ten-year strategic partnership between Youlife's vocational education brand (Tiankun Education) and Dazhou Technician College, covering enrollment, curriculum co-development, training, and employment placement. The disclosure emphasizes expansion of Youlife's national vocational education network and strengthening of its "blue-collar lifetime service platform" ecosystem. While the partnership is operational and strategic in nature rather than a discrete M&A transaction, it represents a material business development that expands the company's educational capacity and geographic presence in Western China, with management commentary highlighting its significance to long-term growth strategy.
View raw filing on EDGAR →The filing discloses two principal executive changes: (1) Barbara Humpton's retirement as CEO effective October 1, 2026, and (2) Thrasyvoulos Moraitis's appointment as CEO on the same date, along with Michael Blitzer's appointment as Executive Chair effective immediately. While both a departure and appointment occur, the central narrative focuses on the appointment of Moraitis as the successor CEO—a highly experienced operator in rare earths with detailed compensation terms ($822,000 base salary, $5M RSU award, $1.5M inducement RSUs, $6.5M performance RSUs, and $4M make-whole award). The filing emphasizes his qualifications and role in leading the company through the Serra Verde merger integration and operational execution, making the appointment the primary disclosed event.
View raw filing on EDGAR →